A research-stage sensing architecture for continuous, non-invasive monitoring of treatment-conditioned biological response.
AI struggles when the biology that determines patient response is unobserved. We are designing wearables intended to make that biology visible.
Instead of asking imaging alone to infer future trajectory, Conquer Medical’s concepts aim to capture the physiological signals through which treatment response is actually expressed: neural activity, circulation, respiration, temperature, tissue oxygenation, motion, and other continuous markers of biological state.
Each device is designed to surface biological response in a form that could be monitored continuously, interpreted clinically, and integrated into patient-specific AI systems.
The devices shown here are research-stage concepts and engineering designs. They are not medical devices, have not been cleared or approved by any regulatory authority, are not available for sale, and are not for clinical or diagnostic use. Any data collection would be conducted only under applicable ethical, consent, and regulatory oversight.
Our approach is not to ask AI to infer missing biology from static data. It is to instrument the patient continuously so treatment response becomes part of the observed state.
The wearables are designed to capture longitudinal physiological signals across treatment, activity, rest, and recovery, creating a live record of response dynamics rather than isolated snapshots.
Continuous data streams are intended to let AI systems learn how this patient responds, not merely how similar patients were labelled in historical datasets.
The aim is safer and more specific monitoring of treatment-conditioned biology in oncology, neurology, and other settings where trajectory matters as much as diagnosis.
We welcome conversation with clinicians, engineers, translational researchers, and strategic partners interested in wearable systems for patient-specific biological monitoring.